LYRA

Lyra Therapeutics, Inc. - Common Stock (LYRA)

About Lyra Therapeutics, Inc. - Common Stock (LYRA)

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Details

Daily high

$4.02

Daily low

$3.76

Price at open

$3.93

52 Week High

$37.50

52 Week Low

$2.84

Market cap

7.0M

Dividend yield

0.00%

Volume

17,202

Avg. volume

97,359

P/E ratio

-.17

Lyra Therapeutics, Inc. - Common Stock News